Levels of PAR-1 were significantly raised in subjects with COVID-19 T2DM versus the control group (50.76 ± 31.21 vs. controls 23.99 ± 12.68) (Table 1). The gene discussed is F2R; the disease is type 2 diabetes mellitus.